抗发作药物是SUDEP的罪祸首吗?
Danist Leosuthamas1, Chusak Limotai2,3,4, Nattawut Unwanatham5
1Division of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
概括
卡巴马西平 (CBZ) 降低了心率变化 (HRV),这是心脏突然死亡的危险因素. 在服用CBZ的患者中监测HRV,特别是那些有性突发意外死亡 (SUDEP) 风险的患者.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 减少心率变化 (HRV) 是突然心脏死亡的潜在生物标志物.
- 抗发作药物 (ASM) 用于治疗,但它们对HRV的影响尚未完全理解.
- 中突然意外死亡 (SUDEP) 是管理中的一个重要问题.
研究的目的:
- 调查ASM对HRV参数的影响.
- 评估与SUDEP相关的因素对ASM-HRV关系的影响.
- 为患有心脏事件风险的患者提供ASM使用指南.
主要方法:
- 从监测单位招募的患者 (2013年1月至2021年12月).
- 使用Python®软件在清醒和睡眠期间分析了5分钟心电图 (ECG) 时代.
- 使用线性回归来评估ASM与HRV的关联,并根据临床特征和同时发生的ASM进行调整.
主要成果:
- 卡巴马泽平 (CBZ), levetiracetam (LEV),拉莫特里金 (LTG) 和克罗纳泽巴姆 (CZP) 显著改变了睡眠HRV.
- 即使经过调整 (p=0.045),CBZ也表现出负面影响,降低HRV (较低的SDNN),即使经过调整 (p=0.045).
- 不管调整如何,LEV和克罗纳泽巴姆 (CZP) 显示出相反的效果,增加HRV.
结论:
- CBZ对HRV有负面影响,建议在患有SUDEP风险的患者中谨慎使用.
- 建议在长期CBZ治疗之前和期间进行治疗前和随访HRV评估.
- LEV和CZP可能对患者的HRV产生有益影响.
更多相关视频
10:25Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
Published on: March 27, 2021
6.1K
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.7K
相关概念视频
01:24Epilepsy and Seizures: Overview
230
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
230
01:20Antiepileptic Drugs: Potassium Channel Activators
221
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
221
01:17Antiepileptic Drugs: Calcium Channel Blockers
477
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
477
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
354
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
354
01:08Antiepileptic Drugs: Sodium Channel Blockers
699
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
699
01:14Antiepileptic Drugs: Glutamate Antagonists
435
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
435